Company Filing History:
Years Active: 2009-2021
Title: Neil Tremayne - Innovator in Pyrimidinone Derivatives
Introduction
Neil Tremayne is a notable inventor based in Great Britain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific enzyme activities. His work focuses on the preparation and uses of pyrimidinone derivatives, which have potential applications in treating various proliferative disorders.
Latest Patents
Neil Tremayne holds a patent titled "Preparation And Uses Of Pyrimidinone Derivatives." This invention relates to compounds of formula (I), which function as inhibitors of cell division cycle 7 (Cdc7) kinase enzyme activity. The compounds are defined by specific parameters, including X, R1, R2, and n. The invention also encompasses processes for preparing these compounds, pharmaceutical compositions that include them, and their applications in treating conditions such as cancer, where Cdc7 kinase activity is implicated. Notably, Neil Tremayne has 2 patents registered under his name.
Career Highlights
Throughout his career, Neil Tremayne has focused on innovative approaches to drug development. His research has contributed to a deeper understanding of enzyme inhibitors and their therapeutic potential. His work is characterized by a commitment to advancing medical science and improving treatment options for patients.
Collaborations
Neil Tremayne has collaborated with Emma L Carswell, working together on the development of pyrimidinone derivatives. Their partnership has been instrumental in advancing their research and bringing innovative solutions to the field of medicinal chemistry.
Conclusion
Neil Tremayne is a dedicated inventor whose work in pyrimidinone derivatives showcases his commitment to advancing medical treatments. His contributions to the field highlight the importance of innovation in addressing complex health challenges.